Carregant...
Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension
Objective—To investigate the relation between the severity of pulmonary hypertension and the outcome of medical treatment. Methods—98 patients with primary pulmonary hypertension—nine (6%) with systemic disease and pulmonary hypertension and 39 (27%) with thromboembolic pulmonary hypertension—receiv...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
1998
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1728783/ https://ncbi.nlm.nih.gov/pubmed/9813561 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|